EA201690232A1 - Генетически стабильный онколитический рнк вирус, способ его производства и применения - Google Patents

Генетически стабильный онколитический рнк вирус, способ его производства и применения

Info

Publication number
EA201690232A1
EA201690232A1 EA201690232A EA201690232A EA201690232A1 EA 201690232 A1 EA201690232 A1 EA 201690232A1 EA 201690232 A EA201690232 A EA 201690232A EA 201690232 A EA201690232 A EA 201690232A EA 201690232 A1 EA201690232 A1 EA 201690232A1
Authority
EA
Eurasian Patent Office
Prior art keywords
virus
human
manufacture
application
rna virus
Prior art date
Application number
EA201690232A
Other languages
English (en)
Other versions
EA032977B1 (ru
Inventor
Дите Венскус
Иварс Калвиньш
Даце Пьянова
Рамона Петровска
Юргис Аузиньш
Original Assignee
Дитесан Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дитесан Лтд. filed Critical Дитесан Лтд.
Publication of EA201690232A1 publication Critical patent/EA201690232A1/ru
Publication of EA032977B1 publication Critical patent/EA032977B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32311—Enterovirus
    • C12N2770/32332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

В способе производства модифицированного энтеровируса ECHO 7 типа посредством модификации природного ECHO 7 вируса, выделенного известным способом из фекалий человека и идентифицированного по последовательности генома, модификацию осуществляли изначально путем проведения адаптации вируса в раковых клетках, ослабленных противоопухолевым средством дакарбазином, затем пассировали модифицировалнный вирус в культуре эмбриональных фибробластов человека с последующим репродуцированием в клетках меланомы человека и дальнейшим пассированием в культуре эмбриональных фибробластов человека, затем обрабатывали рибавирином, выделяли и очищали известным способом. Модифицированный вирус является пригодным в лечении ряда опухолей.
EA201690232A 2013-07-16 2014-07-16 Генетически стабильный онколитический рнк вирус, способ его производства и применения EA032977B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13176757.6A EP2826856B9 (en) 2013-07-16 2013-07-16 Genetically stable oncolytic RNA virus, method of manufacturing and use thereof
PCT/EP2014/065277 WO2015007788A1 (en) 2013-07-16 2014-07-16 Genetically stable oncolytic rna virus, method of manufacturing and use thereof

Publications (2)

Publication Number Publication Date
EA201690232A1 true EA201690232A1 (ru) 2016-05-31
EA032977B1 EA032977B1 (ru) 2019-08-30

Family

ID=48790285

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690232A EA032977B1 (ru) 2013-07-16 2014-07-16 Генетически стабильный онколитический рнк вирус, способ его производства и применения

Country Status (16)

Country Link
US (2) US10174291B2 (ru)
EP (2) EP2826856B9 (ru)
JP (1) JP6293882B2 (ru)
CN (2) CN110129284A (ru)
AU (1) AU2014292114B2 (ru)
BR (1) BR112016000874B1 (ru)
CA (1) CA2917584C (ru)
EA (1) EA032977B1 (ru)
ES (1) ES2566146T3 (ru)
GE (1) GEP201706763B (ru)
HK (1) HK1219500A1 (ru)
MD (1) MD4480C1 (ru)
MX (1) MX365075B (ru)
PL (2) PL2826856T3 (ru)
UA (1) UA116387C2 (ru)
WO (1) WO2015007788A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109276580B (zh) * 2017-07-21 2021-08-24 厦门大学 一种用于治疗肿瘤的病毒
CN109419818B (zh) * 2017-08-24 2021-08-10 厦门大学 一种用于治疗肿瘤的埃可病毒
CN107669707A (zh) * 2017-11-16 2018-02-09 邹罡 埃可病毒作为溶瘤病毒在抗肿瘤中的应用
CN110064044B (zh) * 2018-01-20 2022-09-09 中国科学院武汉病毒研究所 一种肠道病毒71型的抑制剂及应用
GB201808500D0 (en) 2018-05-23 2018-07-11 Ditesan Ltd Virus and virus use
WO2020035423A1 (en) 2018-08-13 2020-02-20 Ditesan Ltd. Combination therapy of cancer by administrating echo-7 virus and a pharmaceutically effective anti-cancer drug

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4987101A (en) 1988-12-16 1991-01-22 International Business Machines Corporation Method for providing improved insulation in VLSI and ULSI circuits
CN1244583A (zh) * 1998-08-12 2000-02-16 财团法人生物技术开发中心 本土性猪水泡病病毒与其变异株的制备方法及用途
WO2001019380A2 (en) * 1999-09-17 2001-03-22 Pro-Virus, Inc. Oncolytic virus
AUPQ425699A0 (en) * 1999-11-25 1999-12-23 University Of Newcastle Research Associates Limited, The A method of treating a malignancy in a subject and a pharmaceutical composition for use in same
US6602862B1 (en) * 2000-09-19 2003-08-05 Merz Pharma Gmbh & Co., Kgaa 1-Amino-alkylcyclohexanes as trypanocidal agents
AU2002306709A1 (en) * 2001-03-14 2002-09-24 Replicon Technologies, Inc. Oncolytic rna replicons
LV12861B (lv) * 2002-06-14 2002-10-20 Aina Muceniece Imūnstimulators ar pretaudzēja aktivitāti un tā iegūšanas paņēmiens
AU2002953436A0 (en) * 2002-12-18 2003-01-09 The University Of Newcastle Research Associates Limited A method of treating a malignancy in a subject via direct picornaviral-mediated oncolysis
US20080274129A1 (en) * 2003-04-18 2008-11-06 Fikes John D Hla-A2 Tumor Associated Antigen Peptides and Compositions
US20080160031A1 (en) * 2005-01-17 2008-07-03 Viralytics Limited Method and Composition for Treatment of Neoplasms
JP5448840B2 (ja) * 2006-12-22 2014-03-19 プシオクサス・セラピューティクス・リミテッド 腫瘍退縮アデノウイルスの作出およびその使用
WO2010009735A2 (en) * 2008-07-23 2010-01-28 Dako Denmark A/S Combinatorial analysis and repair
CA2689707A1 (en) * 2009-11-16 2011-05-16 Jean-Simon Diallo Identification of the novel small molecule viral sensitizer vse1 using high-throughput screening

Also Published As

Publication number Publication date
PL3022297T3 (pl) 2023-12-18
CN105518128B (zh) 2019-07-09
GEP201706763B (en) 2017-10-25
MX2016000462A (es) 2016-07-26
EP3022297A1 (en) 2016-05-25
US10174291B2 (en) 2019-01-08
CN110129284A (zh) 2019-08-16
UA116387C2 (uk) 2018-03-12
HK1219500A1 (zh) 2017-04-07
CA2917584C (en) 2018-02-27
MD20160014A2 (ru) 2016-07-31
PL2826856T3 (pl) 2016-06-30
JP2016529886A (ja) 2016-09-29
EP2826856B1 (en) 2015-12-23
WO2015007788A1 (en) 2015-01-22
EA032977B1 (ru) 2019-08-30
EP2826856B9 (en) 2016-05-04
BR112016000874A2 (pt) 2017-03-21
US20160376562A1 (en) 2016-12-29
CN105518128A (zh) 2016-04-20
US10435672B2 (en) 2019-10-08
EP2826856A1 (en) 2015-01-21
EP3022297C0 (en) 2023-07-05
CA2917584A1 (en) 2015-01-22
MX365075B (es) 2019-05-22
AU2014292114A1 (en) 2016-02-18
ES2566146T3 (es) 2016-04-11
AU2014292114B2 (en) 2018-12-20
US20190144833A1 (en) 2019-05-16
EP3022297B1 (en) 2023-07-05
MD4480B1 (ru) 2017-05-31
BR112016000874B1 (pt) 2019-07-16
MD4480C1 (ru) 2017-12-31
JP6293882B2 (ja) 2018-03-14

Similar Documents

Publication Publication Date Title
EA201690232A1 (ru) Генетически стабильный онколитический рнк вирус, способ его производства и применения
CY1122275T1 (el) Μεσεγχυματικα στρωματικα κυτταρα και χρησεις που σχετιζονται με αυτα
EA201791443A1 (ru) Естественные киллерные клетки и их применения
EP3372685A3 (en) Cell lines for virus production and methods of use
MX2020006117A (es) Integracion dirigida de acidos nucleicos.
EA201590488A1 (ru) Способы модификации клеток-хозяев
SG10201902574RA (en) Adeno-associated virus vector variants for high efficiency genome editing and methods thereof
EA201690405A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
EA201591671A1 (ru) Аэрированные композиционные материалы, способы их получения и применения
MX2019002495A (es) Metodos para producir virus para la produccion de vacunas.
MX2018004600A (es) Celulas aniquiladoras naturales y células ilc3 y usos de las mismas.
MX2015009037A (es) Enjuague nasal con miel.
MX2021009554A (es) Produccion de virus en cultivos celulares.
BR112013027307A2 (pt) método para tratar uma matriz de tecido; matriz de tecido acelular
JP2013034479A5 (ru)
MY192824A (en) Compound targeting il-23a and tnf-alpha and uses thereof
MX2018003757A (es) Composiciones y metodos para producir celulas dendriticas.
MX2016013631A (es) Celulas huespedes modificadas y usos de las mismas.
CY1123348T1 (el) Μεθοδος για την παρασκευη ενισχυμενων πολυδυναμων βλαστοκυτταρων απο μεσεγχυματικα βλαστοκυτταρα με τη χρηση κλασματος φλοροταννινης
WO2015073625A3 (en) Synergistic genome-nonintegrating reprogramming by micrornas and transcription factors
MX2019002223A (es) Procedimiento mejorado para el cultivo de algas.
EA201001266A1 (ru) Эффективные противоопухолевые парамиксовирусы
MY191081A (en) Compound targetting il-23a and b-cell activating factor (baff) and uses thereof
EA201891335A1 (ru) Добавление аргинина с целью повышения эффективности ацетогенов, ферментирующих газ
EA201390925A1 (ru) Производные санглиферина и способы их получения